HBOT FDA-approved indications: the framework Prestige customers know cold
FDA-approved HBOT indications are specific and well defined. Prestige customers know exactly where their programs sit — and run clinical or wellness offerings with the documentation and confidence patients expect.
Coverage of hyperbaric oxygen therapy consistently returns to one question: what is HBOT actually FDA-approved for? The answer matters because it drives insurance reimbursement pathways, medical directorship standards, and the framework that separates clinical HBOT programs from wellness HBOT programs.
The current FDA-cleared list of HBOT indications is specific — decompression sickness, air or gas embolism, carbon monoxide poisoning, gas gangrene, certain chronic wound conditions in diabetic patients, radiation necrosis, and a handful of others. Programs targeting other applications — traumatic brain injury, long COVID, athletic recovery, general wellness — operate as legitimate off-label or wellness programs with their own well-established informed-consent frameworks and cash-pay models.
Prestige customers succeed on both sides of that framework. Our clinical customers run FDA-indication programs with medical directors, credentialed staff, and insurance intake. Our wellness customers run polished off-label programs with clear consent, transparent cash-pay pricing, and marketing that reflects the value they deliver. Prestige provides the chamber, the install, the documentation, and the ongoing support so every customer opens with clarity about where their program sits and how to run it well.
Talk to us at prestigehyperbaric.com about the right chamber and setup for your program.